Increased frequency of angiotensin-converting enzyme DD genotype in Saudi overweight and obese patients

Annals of Saudi Medicine

Volumn 23, Issue 1-2, 2003, Pages 24-27

  El Hazmi, Mohsen A F ^a   Warsy, Arjumand S ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Angiotensin converting enzyme (ACE); Obesity; Overweight

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DNA FRAGMENT;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CALCULATION; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPID METABOLISM; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; SAUDI ARABIA;

EID: 0037837330     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2003.24     Document Type: Article

References (24)

1. Erdos EG. Angiotensin I-converting enzyme and the changes in our concepts through the years. Hypertension 1990;16:363-70.
2. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme level. J Clin Invest 1990;86:1343-46.
3. Giacchetti G, Faloia E, Sardu C, Camilloni MA, Mariniello B, Gatti C et al. Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes Relat Metab Disord 2000;24(Suppl 2):5142-3.
4. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Co-expression of renin-angiotensin system genes in human adipose tissues. J Hypertension 1999;17:555-60.
5. Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Cornol P. Distribution of plasma angiotensin 1-converting enzyme levels in healthy men: relationship to environment and hormone parameters. J Lab Clin Med 1991;117:33-9.
6. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
7. Winkleman BR, Nauck M, Klein B, Russ AP, Bohm BO et al. Deletion polymorphism of the angiotensin converting enzyme is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med 1996;125:19-25.
8. Lieberman J, Sastre A. Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med 1980;93:8825-6.
9. Dio Y, Yoshizumi H, Yoshirnari M et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996; 39:97-102.
10. Schmidt S, Strojek K, Grezeszezak W, et al. Excess of DD homozygotes in hemodialyzed patients with type II diabetes. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 1997;12:427-9.
11. Huang X, Rantalaiho V, Wirta O, Pasternach A, et al. Relationship of the angiotensin-converting enzyme polymorphism to glucose tolerance, insulin resistance and hypertension in NIDDM. Hum Genet 1998;102:372-8.
12. Wu S, Xiang K, Weng Q. Relationship between angiotensin 1-converting enzyme gene polymorphism and diabetic nephropathy (Chinese). Chung Hua I H Sueh Tsa Chih 1997;77:183-6.
13. Vleming LJ, Vaan der Pizl JW, Lemkes HH, et al. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. Clin Nephrol 1999;51: 133-40.
14. Grzeszczak W, Zukowska-Szczechowka E. The significance of candidate genes polymorphism in the development of diabetes nephropathy. Wiad Lek 1998;51(Suppl 2):11-23.
15. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, et al. The deletion/insertion polymorphism of the angiotensin converting gene and cardiovascular-renal risk. J Hypertens 1997;15:1579-92.
16. Butler R, Morris AD, Struthers AD. Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin Sci 1997;93:391-400.
17. Hennes MM, O'Shanghnessy IM, Kelly TM, Labelle P, Egan BM, Kissebah AH. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension 1996;28:120-6.
18. Kunkel LM, Smith KD, Boyer SH, et al. Analysis of human γ-chromosome specific reiterated DNA in chromosome variant. Proc Natl Acad Sci 1977;74:1245-9.
19. Nakai K, Itoh C, Mirua Y, Hotta K, Musha T, Itoh T. Miyakawa T et al. Deletion polymorphism of the angiotensin-1-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-202.
20. Steen MS, Foianin KR, Youngblood EB, Kinnick TR, Jacob S, Heuriksen ET. Interactions of exercise training and ACE inhibition on insulin action in obese Sucker rats. J Appl Physiol 1999;86:2044-51.
21. Cooper R, McFarlane-Anderson N, Bennett FI, Wilks R, Puras A, et al. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J Hum Hypertens 1997;11:107-11.
22. Fogari R, Zoppi A, Lazzari P, Preti P, Mugellini A, Corradi L, et al. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. J Cardiovasc Pharmacol 1998;32:616-20.
23. Barton M, Carmona R, Morawietz H, d'Uscio LV, Goettch W, Hillen H, et al. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension 2000;35:329-36.
24. Karlsson C, Lindall K, Ottusson M, Sjostrom L, Carlsson B, Carlsson LM. Human adipose tissue expresses angiotensinogen and enzyme required for its conversion to angiotensin II. J Clin Endocrinol Metab 1998;83:3925-9.